Trump's Executive Order on Drug Prices

Donald Trump announced his intention to sign an executive order on Monday that would direct the United States — United States Department of Health and Human Services to tie United States — Medicare payments for certain medications to the lowest prices paid by other countries. This 'most favored nation' policy aims to reduce drug costs in the United States, a goal Donald Trump has pursued since his first term. The proposal, which primarily targets drugs covered by United States — Medicare Part B, is expected to face strong opposition from the Pharmaceutical industry, which argues it will negatively impact profits and innovation. A similar effort by Donald Trump in 2020 was blocked by a court order and later abandoned by the United States — Presidency of Joe Biden. The move is presented as a way to ensure the United States is treated fairly in global drug pricing and to reduce healthcare costs for its citizens, particularly the 70 million older Americans covered by United States — Medicare.